This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: University of Pennsylvania. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Evgeniy Eruslanov: Innovator in Anti-Tumor Therapies
Introduction
Evgeniy Eruslanov is a notable inventor based in Havertown, PA (US). He has made significant contributions to the field of cancer research through his innovative work on anti-tumor therapies. His research focuses on enhancing the body's immune response to tumors, which is crucial in the fight against cancer.
Latest Patents
Evgeniy holds 1 patent for his invention titled "Compositions and methods of enhancing anti-tumor response using hybrid neutrophils." This patent describes novel compositions and methods that provide innovative anti-tumor therapies. The invention features a hybrid neutrophil in a non-naturally occurring container, which expresses specific neutrophil-associated and antigen-presenting cell-associated molecules. The methods outlined in the patent aim to inhibit tumor growth, treat tumors, and increase the efficacy of antibodies against tumors in subjects.
Career Highlights
Evgeniy is affiliated with the University of Pennsylvania, where he conducts his research and develops his innovative therapies. His work is pivotal in advancing cancer treatment methodologies and improving patient outcomes.
Collaborations
Evgeniy collaborates with Steven M Albelda, a fellow researcher who shares his commitment to enhancing cancer therapies. Their partnership exemplifies the collaborative spirit in the scientific community, driving forward the development of effective treatments.
Conclusion
Evgeniy Eruslanov's contributions to cancer research through his innovative patent highlight the importance of developing new therapies to combat tumors. His work at the University of Pennsylvania continues to pave the way for advancements in anti-tumor treatments.